Family Office Briefing on research bySavills·Jul 12, 2025
Seattle Q2 2025 Life Sciences Market Overview
Seattle life sciences VC funding reached $906.7 million year-to-date in Q2 2025 — family offices should consider co-GP opportunities with strong operators.
Key Metrics
| Metric | Value |
|---|---|
| Venture Capital Funding | 906.7M |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Savills
Building a thesis around Seattle? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.